Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $5.2750 (3.94%) ($4.9500 - $5.3700) on Fri. May. 15, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 9.9% (three month average) | RSI | 71 | Latest Price | $5.2750(3.94%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.3% a day on average for past five trading days. | Weekly Trend | BCRX advances 21.8% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) SLV(7%) TLT(7%) BWX(6%) GLD(6%) TIP(6%) | Factors Impacting BCRX price | BCRX will decline at least -4.95% in a week (0% probabilities). XOP(-9%) XLE(-9%) XAR(-9%) XLF(-8%) PAVE(-8%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | | | | Market Trend Strength | -4.95% (StdDev 9.9%) | Hourly BBV | 1.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $5.24(0.67%) | 10 Day Moving Average | $4.68(12.71%) | 20 Day Moving Average | $4.11(28.35%) | To recent high | -4.4% | To recent low | 3.9% | Market Cap | $931m | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |